CLINICAL_TRIALS
trial_result
· 2010-02-08
Clinical Trial Update: Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions [Phase 3]
Summary
Phase 3 study of a 2.25 mm sirolimus-eluting stent for coronary artery lesions has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-02-08